GlassScriptPhysician profile
Edgar Remotti
NPI 1780212563
$9,710.88
in general payments reported to CMS, 2019-2025
10 companies · $9,711 in 2025
The $9,711 reported for 2025 was more than what 95% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $9,711.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,666 · Travel and Lodging: $4,045.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,666.14 |
| Travel and Lodging | $4,044.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,095.63 | 2025 | Wavewriter Alpha Prime 16, General - Therapies, General - Pain Management |
| Medtronic, INC. | $2,365.49 | 2025 | Intellis Adaptivestim, Synchromedii, Inceptiv |
| Abbott Laboratories | $1,277.94 | 2025 | Proclaim, Eterna |
| Globus Medical, INC. | $831.85 | 2025 | Senza |
| Mml US, INC. | $387.12 | 2025 | Reactiv8 |
| Biotronik Nro, INC. | $315.52 | 2025 | Prospera |
| Spr Therapeutics, INC | $195.63 | 2025 | Sprint Pns System |
| Saluda Medical Americas, INC. | $135.38 | 2025 | Evoke |
| Intrinsic Therapeutics | $74.27 | 2025 | Barricaid Acd (Annular Closure Device) |
| Spine Wave, INC. | $32.05 | 2025 | Salvo Spine System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edgar Remotti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.